Neotropix Email Format
Biotechnology ResearchPennsylvania, United States51-200 Employees
Neotropix is a biotechnology company focused on developing and commercializing systemically deliverable oncolytic viruses to treat cancers, particularly neuroendocrine cancers such as small cell lung cancer and neuroblastoma. By leveraging naturally occurring viruses that preferentially target tumors, the company aims to translate these discoveries into products that address difficult-to-treat cancers for patients. Based in Malvern, Pennsylvania, Neotropix operates within the biotechnology research sector and targets clinical applications that aim to improve outcomes for cancer patients. The organization emphasizes scientific advancement and the translation of its virus-based approaches into potential cancer therapies, positioning itself as a player in the cancer treatment landscape. Neotropix appears to be a mid-sized enterprise focused on innovative cancer treatments rather than conventional therapeutics, with a stated commitment to making a difference in patients’ lives through its research.